A pioneer in reproductive psychiatry, Samantha Meltzer-Brody, MD, MPH, investigates new therapeutics for depression during and after pregnancy. She is featured in this Q &A.
Despite how common perinatal depression is, the FDA has only approved one drug specifically to treat it. Samantha Meltzer-Brody, MD, MPH, the Assad Meymandi Distinguished Professor and Chair of the UNC Department of Psychiatry and Director of the UNC Center for Women’s Mood Disorders, helped usher that first treatment, called brexanolone, through clinical trials. Read more at the website Drug Discovery News.